SPONSOR
Nanjing First Hospital, Nanjing Medical University
Total Trials
6
Recruiting
6
Phases
N/A
Conditions studied: Acute Myocardial Infarction (AMI)Lung CancersPancreatic CancerNeuroendocrine TumorsThyroid CancerPCICoronary Arterial Disease (CAD)Calcified Coronary LesionsNeuroblastoma (NB)Intracranial Artery Stenosis
Nanjing First Hospital, Nanjing Medical University is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Acute Myocardial Infarction (AMI), Lung Cancers, Pancreatic Cancer, Neuroendocrine Tumors.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Nanjing First Hospital, Nanjing Medical University
How many clinical trials has Nanjing First Hospital, Nanjing Medical University sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Nanjing First Hospital, Nanjing Medical University, of which 6 are actively recruiting participants. These trials cover conditions including Acute Myocardial Infarction (AMI), Lung Cancers, Pancreatic Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Nanjing First Hospital, Nanjing Medical University research focus on?
Nanjing First Hospital, Nanjing Medical University clinical trials span Acute Myocardial Infarction (AMI), Lung Cancers, Pancreatic Cancer, Neuroendocrine Tumors, Thyroid Cancer, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Nanjing First Hospital, Nanjing Medical University clinical trial?
To participate in a Nanjing First Hospital, Nanjing Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nanjing First Hospital, Nanjing Medical University trials with current recruitment status updated daily.
Clinical Trials by Nanjing First Hospital, Nanjing Medical University
NCT07537296
Recruiting
Coronary and Myocardial Evaluation by Cardiac CT for Acute Myocardial Infarction
Acute Myocardial Infarction (AMI)
NCT06937112
Recruiting
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
Lung Cancers
NCT07093788
Recruiting
Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions
PCI
NCT07064746
Recruiting
Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
Neuroblastoma (NB)
NCT05397405
Recruiting
Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome
Intracranial Artery Stenosis
NCT07745881
Recruiting
Analgesic Effects of Retro-superior Costotransverse Ligament Space Block for Video-assisted Thoracoscopic Surgery
Nerve Block
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology